Bronstein, Gewirtz & Grossman, LLC Notifies Apyx Medical Corporation (APYX) Investors of Class Action and Encourages Investors to Contact the Company

NEW YORK, June 10, 2022 /PRNewswire/ — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC advises investors that a class action lawsuit has been filed against Apyx Medical Corporation (“Apyx” or the “Company”) (NASDAQ: APYX) and certain of its officers, on behalf of all persons and entities who have purchased or otherwise acquired Apyx securities between May 12, 2021 and March 11, 2022, inclusive (the “Class Period”). These investors are encouraged to join this deal by visiting the company’s website: www.bgandg.com/apyx.

This class action seeks damages against the defendants for alleged violations of federal securities laws.

This Complaint alleges that throughout the Class Period, the Defendants made materially false and misleading statements regarding the Company’s business, operations and prospects. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx’s Advanced Energy products were used for off-label indications; (2) these off-label uses have resulted in an increase in the number of medical device reports filed by Apyx of serious adverse events; (3) as a result, the Company was reasonably likely to be subject to regulatory review; (4) as a result of the foregoing, the Company’s financial results would be adversely affected; and (5) as a result, defendants’ positive statements about the company’s business, operations and prospects were materially misleading and/or lacked reasonable basis.

A class action lawsuit has already been filed. If you would like to view a copy of the complaint, you can visit the firm’s website: www.bgandg.com/apyx or you can contact Peretz Bronstein, Esq. or its lawyer and head of customer relations, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Apyx, you have until August 5, 2022 ask the court to appoint you as the main plaintiff. Your ability to participate in any collection does not require you to serve as the lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The company has fetched hundreds of millions of dollars for investors nationwide. Lawyer advertisement. Prior results do not guarantee similar results.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein Where Yael Nathanson
212-697-6484 | [email protected]

SOURCE Bronstein, Gewirtz & Grossman, LLC